|
1
|
Richards JB, Zheng HF and Spector TD:
Genetics of osteoporosis from genome-wide association studies:
Advances and challenges. Nat Rev Genet. 13:576–588. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Black DM and Rosen CJ: Clinical practice.
Postmenopausal osteoporosis. N Engl J Med. 374:254–262. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim KM, Park SJ, Jung SH, Kim EJ, Jogeswar
G, Ajita J, Rhee Y, Kim CH and Lim SK: MiR-182 is a negative
regulator of osteoblast proliferation, differentiation, and
skeletogenesis through targeting FoxO1. J Bone Miner Res.
27:1669–1679. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu B, Chang J, Liu Y, Li J, Kevork K,
Al-Hezaimi K, Graves DT, Park NH and Wang CY: Wnt4 signaling
prevents skeletal aging and inflammation by inhibiting nuclear
factor-κB. Nat Med. 20:1009–1017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Long F: Building strong bones: Molecular
regulation of the osteoblast lineage. Nat Rev Mol Cell Biol.
13:27–38. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mulder JE, Kolatkar NS and LeBoff MS: Drug
insight: Existing and emerging therapies for osteoporosis. Nat Clin
Pract Endocrinol Metab. 2:670–680. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo AJ, Choi RC, Cheung AW, Chen VP, Xu
SL, Dong TT, Chen JJ and Tsim KW: Baicalin, a flavone, induces the
differentiation of cultured osteoblasts: An action via the
Wnt/beta-catenin signaling pathway. J Biol Chem. 286:27882–27893.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Reid IR: Short-term and long-term effects
of osteoporosis therapies. Nat Rev Endocrinol. 11:418–428. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chang TC, Yu D, Lee YS, Wentzel EA, Arking
DE, West KM, Dang CV, Thomas-Tikhonenko A and Mendell JT:
Widespread microRNA repression by Myc contributes to tumorigenesis.
Nat Genet. 40:43–50. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lian JB, Stein GS, van Wijnen AJ, Stein
JL, Hassan MQ, Gaur T and Zhang Y: MicroRNA control of bone
formation and homeostasis. Nat Rev Endocrinol. 8:212–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Anfossi S, Babayan A, Pantel K and Calin
GA: Clinical utility of circulating non-coding RNAs-an update. Nat
Rev Clin Oncol. 15:541–563. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hackl M, Heilmeier U, Weilner S and
Grillari J: Circulating microRNAs as novel biomarkers for bone
diseases-complex signatures for multifactorial diseases? Mol Cell
Endocrinol. 432:83–95. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng HC, Bae Y, Dawson BC, Chen Y, Bertin
T, Munivez E, Campeau PM, Tao J, Chen R and Lee BH: MicroRNA
miR-23a cluster promotes osteocyte differentiation by regulating
TGF-β signalling in osteoblasts. Nat Commun. 8:150002017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li D, Liu J, Guo B, Liang C, Dang L, Lu C,
He X, Cheung HY, Xu L, Lu C, et al: Osteoclast-derived exosomal
miR-214-3p inhibits osteoblastic bone formation. Nat Commun.
7:108722016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Seeliger C, Karpinski K, Haug AT, Vester
H, Schmitt A, Bauer JS and van Griensven M: Five freely circulating
miRNAs and bone tissue miRNAs are associated with osteoporotic
fractures. J Bone Miner Res. 29:1718–1728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Weilner S, Schraml E, Wieser M, Messner P,
Schneider K, Wassermann K, Micutkova L, Fortschegger K, Maier AB,
Westendorp R, et al: Secreted microvesicular miR-31 inhibits
osteogenic differentiation of mesenchymal stem cells. Aging Cell.
15:744–754. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Weilner S, Skalicky S, Salzer B, Keider V,
Wagner M, Hildner F, Gabriel C, Dovjak P, Pietschmann P,
Grillari-Voglauer R, et al: Differentially circulating miRNAs after
recent osteoporotic fractures can influence osteogenic
differentiation. Bone. 79:43–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mandourah AY, Ranganath L, Barraclough R,
Vinjamuri S, Hof RV, Hamill S, Czanner G, Dera AA, Wang D and
Barraclough DL: Circulating microRNAs as potential diagnostic
biomarkers for osteoporosis. Sci Rep. 8:84212018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen J, Li K, Pang Q, Yang C, Zhang H, Wu
F, Cao H, Liu H, Wan Y, Xia W, et al: Identification of suitable
reference gene and biomarkers of serum miRNAs for osteoporosis. Sci
Rep. 6:363472016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramírez-Salazar EG, Carrillo-Patiño S,
Hidalgo-Bravo A, Rivera-Paredez B, Quiterio M, Ramírez-Palacios P,
Patiño N, Valdés-Flores M, Salmerón J and Velázquez-Cruz R: Serum
miRNAs miR-140-3p and miR-23b-3p as potential biomarkers for
osteoporosis and osteoporotic fracture in postmenopausal
Mexican-Mestizo women. Gene. 679:19–27. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
You L, Pan L, Chen L, Gu W and Chen J:
miR-27a is essential for the shift from osteogenic differentiation
to adipogenic differentiation of mesenchymal stem cells in
postmenopausal osteoporosis. Cell Physiol Biochem. 39:253–265.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wei Q, He M, Chen M, Chen Z, Yang F, Wang
H, Zhang J and He W: Icariin stimulates osteogenic differentiation
of rat bone marrow stromal stem cells by increasing TAZ expression.
Biomed Pharmacother. 91:581–589. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wei Q, Zhang J, Hong G, Chen Z, Deng W, He
W and Chen MH: Icariin promotes osteogenic differentiation of rat
bone marrow stromal cells by activating the ERα-Wnt/β-catenin
signaling pathway. Biomed Pharmacother. 84:931–939. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wu Y, Xia L, Zhou Y, Xu Y and Jiang X:
Icariin induces osteogenic differentiation of bone mesenchymal stem
cells in a MAPK-dependent manner. Cell Prolif. 48:375–384. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu H, Xiong Y, Zhu X, Gao H, Yin S, Wang
J, Chen G, Wang C, Xiang L, Wang P, et al: Icariin improves
osteoporosis, inhibits the expression of PPARγ, C/EBPα, FABP4 mRNA,
N1ICD and jagged1 proteins, and increases Notch2 mRNA in
ovariectomized rats. Exp Ther Med. 13:1360–1368. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang Z, Wang D, Yang D, Zhen W, Zhang J
and Peng S: The effect of icariin on bone metabolism and its
potential clinical application. Osteoporos Int. 29:535–544. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Y, Shen L, Mao Z, Wang N, Wang X,
Huang X, Hu Y, Shou D and Wen C: Icariin enhances bone repair in
rabbits with bone infection during post-infection treatment and
prevents inhibition of osteoblasts by vancomycin. Front Pharmacol.
8:7842017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Y, Li L, Tang Y, Yang J, Jin Y and Ma
C: Icariin promotes osteogenic differentiation by suppressing Notch
signaling. Eur J Pharmacol. 865:1727942019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kim KM and Lim SK: Role of miRNAs in bone
and their potential as therapeutic targets. Curr Opin Pharmacol.
16:133–141. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ren H, Yu X, Shen G, Zhang Z, Shang Q,
Zhao W, Huang J, Yu P, Zhan M, Lu Y, et al: MiRNA-seq analysis of
human vertebrae provides insight into the mechanism underlying
GIOP. Bone. 120:371–386. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Xu Q, Cui Y, Luan J, Zhou X, Li H and Han
J: Exosomes from C2C12 myoblasts enhance osteogenic differentiation
of MC3T3-E1 pre-osteoblasts by delivering miR-27a-3p. Biochem
Biophys Res Commun. 498:32–37. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma Y, Shan Z, Ma J, Wang Q, Chu J, Xu P,
Qin A and Fan S: Validation of downregulated microRNAs during
osteoclast formation and osteoporosis progression. Mol Med Rep.
13:2273–2280. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo D, Li Q, Lv Q, Wei Q, Cao S and Gu J:
miR-27a targets sFRP1 in hFOB cells to regulate proliferation,
apoptosis and differentiation. PLoS One. 9:e913542014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Liu C, Zhang A, Yin S, Wang T, Wang
Y, Wang M, Liu Y, Ying Q, Sun J, et al: Down-regulation of long
non-coding RNA MEG3 suppresses osteogenic differentiation of
periodontal ligament stem cells (PDLSCs) through miR-27a-3p/IGF1
axis in periodontitis. Aging (Albany NY). 11:5334–5350. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gong Y, Lu J, Yu X and Yu Y: Expression of
Sp7 in Satb2-induced osteogenic differentiation of mouse bone
marrow stromal cells is regulated by microRNA-27a. Mol Cell
Biochem. 417:7–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou X, Zhang Z, Feng JQ, Dusevich VM,
Sinha K, Zhang H, Darnay BG and de Crombrugghe B: Multiple
functions of Osterix are required for bone growth and homeostasis
in postnatal mice. Proc Natl Acad Sci USA. 107:12919–12924. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shi K, Lu J, Zhao Y, Wang L, Li J, Qi B,
Li H and Ma C: MicroRNA-214 suppresses osteogenic differentiation
of C2C12 myoblast cells by targeting Osterix. Bone. 55:487–494.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Compston JE, McClung MR and Leslie WD:
Osteoporosis. Lancet. 393:364–376. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guo L, Chen K, Yuan J, Huang P, Xu X, Li
C, Qian N, Qi J, Shao Z, Deng L, et al: Estrogen inhibits
osteoclasts formation and bone resorption via microRNA-27a
targeting PPARγ and APC. J Cell Physiol. 234:581–594. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gavali S, Gupta MK, Daswani B, Wani MR,
Sirdeshmukh R and Khatkhatay MI: Estrogen enhances human osteoblast
survival and function via promotion of autophagy. Biochim Biophys
Acta Mol Cell Res. 1866:1498–1507. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Anastasilakis AD, Makras P, Pikilidou M,
Tournis S, Makris K, Bisbinas I, Tsave O, Yovos JG and Yavropoulou
MP: Changes of circulating MicroRNAs in response to treatment with
teriparatide or denosumab in postmenopausal osteoporosis. J Clin
Endocrinol Metab. 103:1206–1213. 2018. View Article : Google Scholar : PubMed/NCBI
|
